Literature DB >> 11919216

Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

G Cserni1.   

Abstract

AIMS: To assess the constancy of the histological grade of invasive breast carcinomas by comparing primary tumours with their axillary metastases and local or regional recurrences.
METHODS: Eighty four recurrent invasive breast carcinomas with a primary tumour or previous recurrence were available for histological review from the period 1980 to 2000. These and any further recurrences were graded by one observer.
RESULTS: Nine, 24, and 51 tumours with grades 1, 2, and 3, respectively, recurred. Grade 1, 2, and 3 tumours recurred within a median time of 88, 42, and 23 months, respectively. The intraobserver reproducibility of the histological grade was good (kappa = 0.66), and the grades of the primary tumours and their axillary metastases or next recurrence also exhibited good agreement. However, when further (second to sixth) recurrences were included in the analysis, the agreement between the grade of the tumours and their last recurrence was only moderate (kappa = 0.48). Only two of the nine grade 1 and 15 of the 24 grade 2 tumours retained their grade in their last recurrence.
CONCLUSIONS: Low grade carcinomas require a longer follow up. These long term data support the possibility of a transition from low grade invasive breast carcinomas to higher grade tumours. It is suggested that low grade (well differentiated) breast carcinomas are not a single entity: some may progress to high grade tumours, whereas others appear not to progress.

Entities:  

Mesh:

Year:  2002        PMID: 11919216      PMCID: PMC1769625          DOI: 10.1136/jcp.55.4.293

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Breast cancer treatment and natural history: new insights from results of screening.

Authors:  L Tabár; G Fagerberg; N E Day; S W Duffy; R M Kitchin
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

2.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

3.  Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast.

Authors:  R Diallo; K L Schaefer; C Poremba; N Shivazi; V Willmann; H Buerger; B Dockhorn-Dworniczak; W Boecker
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

Review 4.  Karnofsky Memorial Lecture. Natural history of small breast cancers.

Authors:  S Hellman
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

5.  Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.

Authors:  C A Quiet; D J Ferguson; R R Weichselbaum; S Hellman
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

6.  Prognosis of breast cancer with axillary node metastases after surgical treatment only.

Authors:  N Cascinelli; M Greco; R Bufalino; C Clemente; D Galluzzo; V delle Donne; R de Lellis; V Sacchini; U Veronesi
Journal:  Eur J Cancer Clin Oncol       Date:  1987-06

7.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

8.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Authors:  H F Frierson; R A Wolber; K W Berean; D W Franquemont; M J Gaffey; J C Boyd; D C Wilbur
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

9.  Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component.

Authors:  O T Lampejo; D M Barnes; P Smith; R R Millis
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

10.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  7 in total

1.  Revisiting Epithelial Carcinogenesis.

Authors:  Luis Fernando Méndez-López
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

2.  Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001.

Authors:  T J Anderson; C Davis; F E Alexander; H M Dobson
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

3.  Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yo Oguma; Minami Hirasawa; Satoko Sato; Kei Takase
Journal:  Breast Cancer       Date:  2021-04-26       Impact factor: 4.239

4.  Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.

Authors:  Luay Aswad; Surya Pavan Yenamandra; Ghim Siong Ow; Oleg Grinchuk; Anna V Ivshina; Vladimir A Kuznetsov
Journal:  Oncotarget       Date:  2015-11-03

5.  Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Authors:  Natasha Rekhtman; Patrice Desmeules; Anna M Litvak; Maria C Pietanza; Maria Lauren Santos-Zabala; Ai Ni; Joseph Montecalvo; Jason C Chang; Amanda Beras; Isabel R Preeshagul; Joshua K Sabari; Charles M Rudin; Marc Ladanyi; David S Klimstra; William D Travis; Wei-Chu Lai
Journal:  Mod Pathol       Date:  2019-03-28       Impact factor: 7.842

Review 6.  Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?

Authors:  Gábor Cserni; Anita Sejben
Journal:  Pathol Oncol Res       Date:  2019-11-27       Impact factor: 3.201

7.  Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.

Authors:  E Korsching; J Packeisen; M W Helms; C Kersting; R Voss; P J van Diest; B Brandt; E van der Wall; W Boecker; H Bürger
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.